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Abstract
Introduction: The renal clearance of infused crystalloid fluid is very low during anaesthesia and surgery, but
experiments in conscious sheep indicate that the renal fluid clearance might approach a normal rate when the
adrenergic balance is modified.
Methods: Sixty females (mean age, 32 years) undergoing laparoscopic gynecological surgery were randomized to
control group and received only the conventional anesthetic drugs and 20 ml/kg of lactated Ringer’s over 30 mins.
The others were also given an infusion of 50 μg/kg/min of esmolol (beta1-receptor blocker) or 0.01 μg/kg/min of
phenylephrine (alpha1-adrenergic agonist) over 3 hours. The distribution and elimination of infused fluid were
studied by volume kinetic analysis based on urinary excretion and blood hemoglobin level.
Results: Both drugs significantly increased urinary excretion while heart rate and arterial pressure remained largely
unaffected. The urine flows during non-surgery were 43, 147, and 176 ml in the control, esmolol, and
phenylephrine groups, respectively (medians, P < 0.03). When surgery had started the corresponding values were
34, 65 and 61 ml (P < 0.04). At 3 hours, averages of 9%, 20%, and 25% of the infused volume had been excreted in
the three groups (P < 0.01). The kinetic analyses indicated that both treatments slowed down the distribution of
fluid from the plasma to the interstitial fluid space, thereby preventing hypovolemia.
Conclusions: Esmolol doubled and phenylephrine almost tripled urinary excretion during anesthesia-induced
depression of renal fluid clearance.
Introduction
During general anesthesia and surgery, renal clearance
of crystalloid fluid is only 15% to 20% of that found in
conscious volunteers [1-3]. If not carefully balanced,
fluid therapy entails a risk of inducing edema. Slow
elimination might be counteracted by manipulation of
the adrenergic balance. In awake sheep, b1-receptor sti-
mulation by isoprenaline caused fluid retention and
excessive plasma volume expansion that closely resem-
bles the kinetic situation during anesthesia and surgery.
In contrast, a1-receptor stimulation by phenylephrine
increased urinary excretion [4,5].
The aim of the present study was to examine to what
degree the slow turnover of lactated Ringer’s solution
during anesthesia and surgery can be rectified by infus-
ing esmolol (a b1-receptor blocker) or phenylephrine in
patients undergoing laparoscopic gynecological surgery
during intravenous anesthesia. Based on the previous
animal studies [4,5], our hypothesis was that urinary
excretion would increase in response to esmolol and
phenylephrine. Kinetic analysis was also performed to
elucidate whether the infusions cause an aberrant distri-
bution of fluid.
Safety reasons stipulated that the amounts of drug
provided be low. The rate of infusion of phenylephrine
represented only 1% of that used for hemodynamic sup-
port. Esmolol was given in the starting dose recom-




Between November 2008 and October 2010, 60 Ameri-
can Society of Anesthesiologists (ASA) I patients
between 21 and 49 (mean of 32) years of age were stu-
died during elective laparoscopic removal of ovarian
cysts or laparoscopic supracervical hysterectomy (uterus
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less than 1 kg) performed under intravenous general
anesthesia. The protocol (reference number 080186),
including the sampled blood volume of approximately
75 mL, was approved by the ethics committee of Zhe-
jiang University (Hangzhou, China). Each patient gave
her informed consent to participate.
Procedure
Patients fasted overnight. No premedication was given.
A radial artery catheter was inserted for sampling and
for monitoring arterial blood pressure. Anesthesia was
induced with midazolam 50 μg/kg, propofol 1.5 mg/kg,
cis-atracurium 0.15 mg/kg, and fentanyl 3 μg/kg and
this was followed by endotracheal intubation and
mechanical ventilation. The anesthesia was maintained
with propofol 6 mg/kg per hour and cis-atracurium 0.15
mg/kg per hour; fentanyl was infused at a rate of 2 μg/
kg per hour during the first 30 minutes and then at 1.5
μg/kg per minute; these rates could be slightly adjusted
depending on the depth of anesthesia.
An indwelling catheter was placed into the bladder.
The patients were then randomly assigned by the Excel
random number generator (Microsoft Corporation,
Redmond, WA, USA) to receive a 3-hour continuous
infusion of 10 mL/hour lactated Ringer’s solution that
provided no drug (controls); 50 μg/kg per minute of the
b1-receptor blocker esmolol (Qilu Pharmaceutical Co.,
Shandong, China); or 0.01 μg/kg per minute of the alpha1
adrenergic receptor agonist phenylephrine (Hefeng Phar-
maceutical Co., Shanghai, China). The line was primed to
provide the drug from the first minute. The anesthesia
and the research were managed by two anesthesiologists
blinded to the study drug.
After 10 minutes for adjustment to the effects of the
drug, plasma volume expansion was induced by infusing
20 mL/kg of lactated Ringer’s solution (Pharmacia-
Baxter, Shanghai, China) over the course of 30 minutes
via an infusion pump. No other fluid (except drug vehi-
cles) was given. No study data were collected after
termination of the anesthesia.
Measurements
Monitoring included pulse oximetry, electrocardiogra-
phy, heart rate, and invasive mean arterial pressure
(MAP). Data were displayed on a multifunction monitor
(Datex-Ohmeda, Hoevelaken, The Netherlands) and
saved digitally. The depth of anesthesia was monitored
by a bispectral index (BIS) sensor applied to the fore-
head. The signal was recorded on a BIS monitor Model
A-2000TM (Aspect Medical System, Natick, MA, USA).
Urine output was measured every 20 minutes during the
study. Arterial blood samples (2 mL each) were col-
lected every 5 minutes during the first 60 minutes and
every 10 minutes during the following 120 minutes. The
blood hemoglobin (Hb) concentration was measured on
a GEM Premier 3000 (Instrumentation Laboratory, Lex-
ington, IL, USA). Duplicate samples collected at baseline
ensured a coefficient of variation of 1.5%. Blood loss was
assessed from the content of blood in suction bottles
and on sponges.
Kinetic analysis
The distribution and elimination of fluid were analyzed
by a two-volume kinetic model [1-7] with a novel adapta-
tion that allows analysis of uneven distribution (Figure 1).
Fluid was infused at rate Ro to increase the volume of
central body fluid space Vc to vc. The rate of elimination
was given as the product of the volume expansion of Vc
and the elimination rate constant, k10 (unit: per minute).
Perspiratio insensibilis was accounted for by constant ko,
which was preset to 0.4 mL/minute. Distribution of fluid
to the peripheral body fluid space Vt was governed by k12
and its return from vt to vc by rate constant k21. The dif-
ferential equations are the following:
dvc/dt = Ro − ko − k10(vc − Vc)− k12(vc − Vc) + k21(vt − Vt)
dvt/dt = k12(vc − Vc)− k21(vt − Vt).
The Hb-derived fractional plasma dilution was used to
indicate the volume expansion of Vc resulting from the
infusion:
(vc − Vc)/Vc = [(Hb/hb)− 1]/(1−Hct),
where Hct stands for hematocrit. Symbols in capital
letters denote baseline values. A correction for the effect
of blood sampling and blood loss was made on the
plasma dilution [5].
The primary parameters in the model (Vc, k12, and k21)
were estimated by applying a non-linear least-squares
Figure 1 The kinetic model used to analyze the distribution of
infused fluid. ko, fluid loss by evaporation through skin and
airways; k10, rate constant for fluid leaving the system; k12, rate
constant for fluid passing from vc to vt; k21, rate constant for fluid
passing from vt to vc; Ro, rate of infusion; vc, size of central body
fluid space during fluid therapy; Vc, size of central body fluid space
at baseline; vt, size of peripheral body fluid space during fluid
therapy; Vt, size of peripheral body fluid space at baseline.
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regression routine (fminsearch) by using Matlab R2010a
software (The MathWorks, Inc., Natick, MA, USA),




urine volume/AUC for (vc - Vc),
where AUC is the area under the curve. The renal
clearance is the product of Vc and k10.
Statistical analysis
The study was powered (80%) to detect a doubling of
urinary excretion in any of the study groups as com-
pared with the controls on the basis of the ratio
between the excreted urine and infused fluid previously
found during surgery [2,3]. An interim analysis was
made after 42 patients.
Data are presented as the median and 25th to 75th
percentile range. Comparisons between the three groups
were made by the Kruskal-Wallis test, which, if signifi-
cant, this is so. was followed by the Mann-Whitney U
test for post hoc analysis. Changes were assessed by the
Wilcoxon matched-pair test. Correlations between vari-
ables were studied by simple and multiple regression
analysis by using square root transformation if distribu-
tion was skewed. A P value of less than 0.05 was consid-
ered statistically significant.
Results
Demographics, hemodynamics, and anesthesia
There were no differences among the three study groups
with respect to baseline parameters, operating time,
blood loss (Table 1), and heart rate (Figure 2, left).
Esmolol infusion was followed by a modest decrease in
MAP during surgery in comparison with baseline (P <
0.01), whereas no change versus baseline occurred in
the other two groups (Figure 2, middle). During surgery,
MAP was 5 mm Hg higher in the phenylephrine group
than in the esmolol group (P < 0.01). Phenylephrine was
also associated with a slightly higher overall MAP than
the other groups (Table 1). The administered amounts
of anesthetic drugs were similar between the groups, but
the esmolol patients received less fentanyl than the
others between 60 and 120 minutes (Table 2). The BIS
recordings were virtually identical (Figure 2, right).
Plasma dilution
The decrease in Hb concentration during the infusions
averaged 25 g/L. There were no differences in Hb-
derived plasma dilution at 30, 60, or 120 minutes, but
both treatment drugs were associated with a slightly
less pronounced plasma dilution at 180 minutes in
comparison with the controls (both differences P <
0.01) (Table 3).
Urinary excretion
The cumulative urinary excretion was significantly larger
in the two treatment groups than in the control group
from 60 minutes onward. At 180 minutes, both treat-
ments had more than doubled urinary excretion and the
ratio between excreted and infused fluid volumes (Krus-
kal-Wallis test, P < 0.01) (Figure 3 and Table 4). Study-
ing only the periods of non-surgery and surgery also
revealed that the urinary excretion was larger and the
urine flow higher in the treatment groups compared
with the control group (Table 4).
Kinetic analysis
Figure 4 shows all individual plasma dilution-time pro-
files together with the optimal curve fit for each group.
The three model parameters - Vc, k12, and k21 - could
be estimated in all experiments (Table 5). The elimina-
tion rate parameter, k10, was higher in the two treatment
groups (P < 0.03 and P < 0.01) than in the control
group. Moreover, k21 was lower in the phenylephrine
group than in the controls (P < 0.02).
Simulations of the fluid distribution showed that the
volume expansion of vc during the infusion was similar
among the groups (Figure 5, top row) and virtually iden-
tical on correction for body weight. However, at 180
minutes, less fluid resided in vc in the phenylephrine
group (90 mL) than in the control and esmolol groups
(P < 0.03).
Fluid was distributed more slowly to vt in the two
treatment groups. At 60 minutes, 59% of the fluid
resided in vt in the control group, 48% in the esmolol











Age, years 32 (27-38) 32 (28-39) 33 (27-41) NS
Body weight, kg 50 (48-55) 53 (49-59) 55 (48-60) NS
Start of surgery,
minutes










60 (40-80) 75 (50-
100)
70 (50-100) NS
Blood loss, mLa 30 (30-55) 35 (25-70) 40 (30-70) NS
MAP, mm Hg
Baseline 88 (81-94) 92 (87-
102)
92 (88-98) NS
Non-surgery 77 (68-80) 78 (73-85) 83 (75-93) NS
Surgery 92 (87-96) 90 (84-92) 95 (85-94) P < 0.03
5 to 180
minutes
82 (59-86) 82 (80-90) 92 (85-94) P < 0.02
Data are the median (25th to 75th percentile) for the group. aCollected by
suction and on sponges, not including blood in removed tissue. MAP, mean
arterial pressure; NS, not significant.
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group, and 43% in the phenylephrine group (P < 0.01;
controls versus phenylephrine P < 0.004) (Figure 5, mid-
dle row). At 180 minutes, the volume in vt did not differ
significantly. The kinetic model slightly overestimated
urinary excretion early in the operations (Figure 5, bot-
tom row).
Linear regression analysis
Simple regression showed that MAP explained 11% of
the variability in the urinary excretion (P < 0.02). How-
ever, multiple regression of the effects of MAP and the
two treatments in turn showed that only the treatment
drugs served as statistically significant predictors of the
urinary excretion and the ratio of excreted/infused fluid.
Discussion
Shifting the catecholamine balance by small amounts of
drug promoted urinary excretion. In the present study,
esmolol doubled and phenylephrine almost tripled the
excretion of infused lactated Ringer’s during laparo-
scopic surgery. Despite the diuretic effect, the modifica-
tion of the adrenergic stimulus pattern was not strong
enough to clearly affect MAP or heart rate.
The average ratio of excreted/infused fluid after 3
hours in the control group (9%) was similar to that
found for acetated Ringer’s during laparoscopic chole-
cystectomy [2] and thyroid surgery [3]. However, even
with the two treatment drugs, urinary excretion was still
far below the 50% to 70% of the infused volume seen
within 3 hours in unstressed volunteers [6] and patients
awaiting laparoscopic surgery [7]. Hence, the adminis-
tered esmolol and phenylephrine were not sufficient to
reverse the strong antidiuretic effect of general anesthe-
sia and surgery. On the other hand, the present results
open up for the use of these drugs when both adrener-
gic and diuretic effects are desired. How long the differ-
ence in urinary excretion during surgery prevails is
unknown. The rate is likely to increase slightly when
anesthesia is terminated [2], but much of the fluid
retained during surgery remains in the body for several
days [8]. In contrast, infusions of crystalloid salt [7] and
glucose [9] solution initiated several hours later are
excreted effectively.
Why the diuretic response to plasma volume expansion
is blunted during anesthesia and surgery is poorly under-
stood but probably can be attributed to vasodilatation,
Figure 2 Heart rate, mean arterial pressure, and bispectral index in patients receiving esmolol, phenylephrine, or sham (controls). Data
are the median values.









0-60 minutes 350 (279-350) 300 (300-337) 290 (250-300) NS
60-120 minutes 316 (291-358) 324 (290-384) 320 (254-400) NS
120-180 minutes 150 (125-225) 210 (168-249) 209 (169-271) NS
Fentanyl, μg
0-60 minutes 250 (250-300) 250 (213-250) 300 (250-300) NS
60-120 minutes 200 (200-250) 150 (150-200) 216 (150-268) P < 0.05
120-180 minutes 100 (100-125) 125 (100-150) 112 (100-150) NS
Cis-atracurium, mg
0-60 minutes 18 (15-20) 18 (15-20) 19 (15-20) NS
60-120 minutes 9 (8-10) 10 (8-10) 9 (7-10) NS
120-180 minutes 0 (0-0) 3 (0-5) 5 (3-5) P < 0.01
Data are the median (25th to 75th percentiles). aP = 0.11; phenylephrine versus controls P < 0.05 (Mann-Whitney test). NS, not significant.
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reduced arterial pressure, and activation of the renin-
aldosterone hormonal axis [1]. Beta-receptor activity may
also play a part. The renal clearance of crystalloid fluid is
slightly higher during open laparotomy [10] than during
laparoscopy [2]; therefore, body position and pneumoper-
itoneum might also depress the renal excretion of fluid.
The physiological effects of intravenous anesthesia also
promote a pronounced plasma volume expansion in
response to crystalloid fluid. When the infusions ended,
60% to 70% of the infused fluid remained in the func-
tional plasma volume, vc. Similarly high percentages
have been reported during isoflurane anesthesia [11]
and during general anesthesia and surgery [2,3,10]. Pro-
nounced plasma volume expansion during infusion
implies that Vc is low, and this is typical of anesthesia-
induced vasodilatation [1]. Here, the small Vc can also
be explained by the relatively low body weight (50 to 55
kg) of the Chinese women studied. The study drugs
might have altered Vc, although the average volume in
the esmolol and phenylephrine groups differed very little
from that of the controls.
A key finding of the kinetic analysis is that both study
drugs slowed down the distribution of fluid from vc to
vt and this probably reflects minimally decreased filtra-
tion due to vasoconstriction. This counteracted any
hypovolemic effect of the increased diuresis during the
first half of the experiments. The fluid volumes residing
in vc became reduced at the end of the study, but, at
that time, differences were hardly worth noting. The
fluid volumes in vt did not differ significantly at 180
minutes (Figure 5).
Variable results for the diuretic effect of esmolol in
previous work suggest that the present study may be
relevant only to anesthetized subjects, possibly because
the renin-aldosterone axis is then stimulated. Complete
b1-receptor blockade in conscious humans lowers the
resting plasma levels of renin, angiotensin, and aldoster-
one but without affecting the diuretic response to
volume loading with saline [12]. In awake sheep, esmo-
lol reduced the diuretic response to infused fluid [13].
Moreover, more fluid tended to accumulate in the extra-
vascular space [13] and this was not encountered during
intravenous anesthesia in humans (Figure 5).
Phenylephrine increases the urinary excretion by pres-
sure diuresis if the increase in MAP is profound, but
also by increasing the release of atrial natriuretic pep-
tides [4]. The small doses of drugs used in the present
study make the role of these mechanisms speculative.
These doses are, in fact, also a limitation since we can-
not outline the diuretic effects of larger amounts. In
sheep, larger doses of phenylephrine markedly lower the
plasma volume [4,5] but this was not an issue in the
present study (Figures 4 and 5).
Another limitation was that the operations were per-
formed on ASA I patients only. Therefore, the effects of
the study drugs on patients with cardiovascular disease
are unclear. Operations were also performed in a teach-
ing hospital and this explains why more than 1 hour
had passed before the surgery started. The restoration of
baseline MAP between 70 and 90 minutes in all groups






















30 minutes 87 (84-96) 87 (84-96) 95 (89-98)
60 minutes 96 (90-104) 95 (90-102) 102 (96-107)
120 minutes 102 (99-105) 105 (98-114) 109 (105-117)
180 minutes 102 (97-105) 105 (99-114) 112 (105-118)
Mean 5-180 minutes 98 (94-103) 99 (93-107) 105 (99-111)
Plasma dilution, no units

























Data are the median (25th to 75th percentiles). aP < 0.01 by the Kruskal-Wallis
test.
Figure 3 Urinary excretion during 3 hours of anesthesia and
surgery. Twenty patients were in each group.
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can be understood on the basis of the late start of the
surgery (Figure 2, middle). Hence, the entire infusion
and the 30-minute post-infusion period of distribution
usually took place before surgery began. However,
plasma volume expansion did not change abruptly when
surgery started; this is not the case during emergence
from anesthesia for laparoscopy [2,14].
The main conclusion still appears to be valid when the
urinary excretion is calculated for periods of apparently
different MAPs and for periods of surgery and non-sur-
gery (Tables 2 and 4). The greatest difference in urinary
excretion occurred early during the procedures (that is,
during periods of non-surgery, when the plasma dilution
was most pronounced). The excreted volumes were
smaller when surgery eventually started (and MAP was
higher). Some statistical differences in urinary excretion
were lost during the second half of the study. However,
the average values for the groups still showed a
continued trend from the first half of the experiments,
namely that the treatment drugs were associated with a
larger urinary excretion.
The novel kinetic analysis used here has the advantage of
being able to estimate all parameters without having to dis-
criminate between two models [1]. Drobin’s model was
first fitted to the data [15] but did not yield reasonable esti-
mates for all curves. A drawback of the present approach is
that the urinary excretion needs to be measured. Model
stability is also increased by the fact that the size of Vt is
not estimated, although it can be inferred in retrospect.
The output is given in the form of Vc and three rate con-
stants. The latter the three rate constants are implied here
should be multiplied by Vc to be converted into clearances,
which is used in virtually all previous publications of
volume kinetics. Yes, it should be “are”. I originally meant
clearance as a concept, but I guess we should aim at them
being three different types of clearance.









Infused volume, mL 1,000 (950-1,100) 1,060 (985-1,180) 1,090 (970-1,190) NS
Cumulative urine volume, mL
40 minutes 13 (3-38) 26 (8-58) 54 (25-91) NS
60 minutes 36 (15-99) 71 (43-150) 135 (58-195) P < 0.05
120 minutes 81 (45-200) 194 (119-352) 236 (97-353) P < 0.01
180 minutes 93 (53-226) 237 (136-416) 276 (168-375) P < 0.01
Non-surgery 43 (27-142) 147 (73-228) 176 (88-285) P < 0.03
Surgery 34 (24-53) 65 (46-122) 61 (39-129) P < 0.04
Urine flow, mL/minute
0-180 minutes 0.51 (0.29-1.22) 1.30 (0.76-2.31) 1.53 (0.93-2.05) P < 0.01
Non-surgery 0.50 (0.25-1.18) 1.33 (0.95-2.63) 1.72 (0.86-2.70) P < 0.01
Surgery 0.51 (0.33-0.83) 0.77 (0.54-1.51) 0.80 (0.54-1.34) NSa
Excreted/infused at 180 minutes, percentage 8.8 (4.9-20.2) 20.4 (13.8-38.0) 25.4 (14.9-36.4) P < 0.01
Data are the median (25th to 75th percentiles). aP = 0.11; esmolol versus controls P < 0.05 (Mann-Whitney test). NS, not significant.
Figure 4 Fractional plasma dilution during and after a 30-minute intravenous infusion of 20 mL/kg of lactated Ringer’s solution in
females undergoing surgery during intravenous anesthesia. Thin lines represent one patient, and the thick line represents the modeled
average. Data are based on the median kinetic data from the analysis shown in Table 5.
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Conclusions
Low doses of esmolol doubled and phenylephrine almost
tripled urinary excretion. These drugs may potentially be
used as diuretics when renal fluid clearance is reduced by
anesthesia and surgery-associated stress. Further work is
needed to elucidate how the diuretic effects of these
drugs are best employed. Phenylephrine might be an
alternative to a conventional diuretic such as furosemide
if the hemodynamics is unstable. Esmolol could be used
as a mild diuretic in patients with supraventricular
arrhythmias.
Key messages
• The clearance of crystalloid fluid is very low during
intravenous anesthesia.






























4.7 (3.3-10.0) P < 0.02
Data are the median (25th to 75th percentile) for the group during the entire
experiment (0 to 180 minutes). k10, rate constant for fluid leaving the system;
k12, rate constant for fluid passing from vc to vt; k21, rate constant for fluid
passing from vt to vc; NS, not significant; vc, size of central body fluid space
during fluid therapy; Vc, size of central body fluid space at baseline; vt, size of
peripheral body fluid space during fluid therapy.
Figure 5 Simulated volume-time curves for the central (Vc) and peripheral (Vt) fluid spaces and urinary excretion. Thin lines are
simulations based on k12, k21, and k10 from each operation, and thick lines are the median for each group. The points in the lower panel are the
measured urinary excretion (median values). k10, rate constant for fluid leaving the system; k12, rate constant for fluid passing from vc to vt; k21,
rate constant for fluid passing from vt to vc; vc, size of central body fluid space during fluid therapy; Vc, size of central body fluid space at
baseline; vt, size of peripheral body fluid space during fluid therapy; Vt, size of peripheral body fluid space at baseline.
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• Small doses of esmolol and phenylephrine increase
the clearance but not up to the normal values for
conscious volunteers.
• These drugs at least doubled the urinary excretion
in comparison with controls.
• The increased diuresis did not cause hypovolemia
as both esmolol and phenylephrine slowed down the
rate of distribution of lactated Ringer’s from plasma
to interstitium.
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